ArticleThe Journal of thoracic and cardiovascular surgery2025
Long-term outcomes of isolated tricuspid surgery in 3706 patients: Implications for the future.
Article in The Journal of thoracic and cardiovascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Association of Predicted Surgical Risk With 3-Year Outcomes After Isolated Tricuspid Valve Surgery: An Analysis of Medicare Beneficiaries.JACC. Advances · 2026Article
- Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery.Journal of the American Heart Association · 2026Article
- Contemporary practice patterns and outcomes of isolated tricuspid valve surgery in North America: systematic review with meta-analysis.Annals of cardiothoracic surgery · 2026Article
- Endoscopic removal of a papillary fibroelastoma of the tricuspid valve.Annals of cardiothoracic surgery · 2026Article
- The current state of isolated tricuspid valve surgery: how it complements transcatheter tricuspid valve interventions.Annals of cardiothoracic surgery · 2026Review
- Outcomes of surgical tricuspid valve intervention after heart transplant.Annals of cardiothoracic surgery · 2026Article
- Transcatheter and surgical management of tricuspid valve disease: multidisciplinary lifetime management considerations.Annals of cardiothoracic surgery · 2026Review
- Right Ventricular Function in Patients With Significant Tricuspid Regurgitation.Reviews in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesEarly and late outcomes of isolated tricuspid surgery in contemporary practice are poorly defined. This statewide analysis evaluated the early and late outcomes of isolated tricuspid repair and replacement.
methodsFrom the Department of Health Care Access and Information of California State admissions database, 3706 patients who underwent isolated tricuspid repair (2419, 65.3%) or replacement (1287, 34.7%) between 1991 and 2020 were identified. Propensity score matching to adjust for 25 differences in baseline characteristics yielded 789 well-matched pairs. The primary outcome was all-cause mortality compared using Cox proportional hazards. The cumulative incidence of tricuspid reoperation and permanent pacemaker were compared in the Fine-Gray model with death as a competing risk. Median follow-up was 4.4 years (range, 0-30 years).
resultsIsolated tricuspid operations increased from 48 in 1991 to 207 in 2021 (P < .001). Patients undergoing repair were similar in age (53.5 vs 54.5 years, P = .17), more often men (44% vs 40% P = .03), and less likely to have endocarditis (21.5% vs 26.8%, P = .002) compared with patients undergoing replacement. Operative mortality was similar between repair and replacement (8.2% vs 9.9%, P = .27), whereas pacemaker rates were higher after replacement (13.7% vs 32.3%, P < .001). Tricuspid repair was associated with reduced mortality at 25 years compared with replacement (58.1% vs 65.5%; hazard ratio, 0.81, 95% CI, 0.70-0.94, P = .005). The cumulative incidence of reoperation was lower with repair (5.6% vs 11.1%, hazard ratio, 0.57, 95% CI, 0.37-0.88, P = .01).
conclusionsTricuspid valve repair is associated with superior early and late outcomes compared with replacement in a statewide administrative dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.